Phio pharmaceuticals fintel

WebbThe average one-year price target for Phio Pharmaceuticals is $73.44 The forecasts range from a low of $72.72 to a high of $75.60. Update Frequency: Monthly PHIO / Phio … WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAI technology makes immune cells more effective in …

Why did Phio Pharmaceuticals stock go up today? - MarketBeat

WebbPHIO Short Sale Transactions - Phio Pharmaceuticals Corp EXTENDED. Day's Range - 52 Week Range - Webb30 mars 2024 · Phio Pharmaceuticals - PHIO News Today $5.99 +0.16 (+2.74%) (As of 03/30/2024 10:41 AM ET) Compare Today's Range $5.75 $5.99 50-Day Range $0.51 $6.85 52-Week Range $3.90 $29.04 Volume 1,039 shs Average Volume 36,447 shs Market Capitalization $6.89 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile … bi wavefront\u0027s https://propupshopky.com

PHIO: Phio Pharmaceuticals Corp - Stock Price, Quote and News

WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAI technology makes immune cells more effective in killing tumor cells. INTASYL is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. WebbPhio Pharmaceuticals Corp (NASDAQ:PHIO) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in … Webb1 mars 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic... date ideas athens ga

Phio Pharmaceuticals and AgonOx, Inc. Announce Collaboration …

Category:Phio Pharmaceuticals (Nasdaq:PHIO) - Stock Price, News

Tags:Phio pharmaceuticals fintel

Phio pharmaceuticals fintel

PHIO Institutional Ownership and Shareholders - Phio …

WebbResumen PHIO Gráfico técnico Phio Pharmaceuticals Corp 5,527 + 0,259 ( + 4,92 %) S 1 semana 1 año Máx. Último cierre 5,268 Rango día 5,321 - 6 Ingresos - Apertura 5,321 52 semanas 3,9 - 29,04... WebbPhio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough, MA 01752 (508) 767-3861 February 7, 2024 VIA EDGAR Securities and Exchange Commission Division of …

Phio pharmaceuticals fintel

Did you know?

WebbAt Phio Pharmaceuticals, our mission is to develop innovative cancer treatments that overcome tumor immunosuppression and weaponize the immune system against … WebbPHIO / Phio Pharmaceuticals Corp - Net Long/Short Value This page provides the net long/short valuations for each institutional holding reported via 13F or NPORT filings. To …

WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology makes immune cells more effective in … Webb13 apr. 2024 · Phio Pharmaceuticals Corporation Aktie ISIN: US71880W4024 · WKN: A3D451 · SYM: PHIO 5,710 USD -1,21 % -0,070 USD Letzter Kurs 06.04.23 · NYSE 5,440 USD 100 STK Geldkurs 06.04.23 6,000 USD 100...

WebbPHIO / Phio Pharmaceuticals Corp off-exchange short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short sales in … WebbPhio Pharmaceuticals stock is traded on Nasdaq as PHIO. The firm is headquartered in Marlborough, Ma. in Middlesex County. The firm's Chairman is Robert Bitterman, …

Webb31 mars 2024 · Phio Pharmaceuticals to begin Phase 1b clinical trial with PH-762 for cSCC March 22, 2024TipRanks Phio Pharmaceuticals reports FY22 EPS ($10.10) vs. one estimate ($10.92) March 22,...

Webb8 apr. 2024 · MARLBOROUGH, Mass., April 8, 2024 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO ), a clinical stage biotechnology company developing the next generation of therapeutics based on... date ideas birminghamWebb6 apr. 2024 · Phio Pharmaceuticals (NASDAQ:PHIO) has a recorded net income of -$11.48 million. PHIO has generated -$10.68 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts … biwa pronunciationWebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly Draw Fullscreen Settings PHIO - Stock Price Chart PHIO [NASD] date ideas around pretoriaWebb10 apr. 2024 · Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. About the company Risk Analysis Earnings have declined by 8.5% per year over past 5 years Has less than 1 year of cash runway Makes less than USD$1m in revenue ($0) Does not have a meaningful market cap ($7M) + 2 more risks See All Risk Checks … date ideas billings mtWebb7 nov. 2024 · Phio Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its... PhioPharma @phio_pharma · May 3, 2024 date ideas ann arbordate ideas beginning with cWebbPhio Pharmaceuticals Corp. is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) … bi way definition